We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




All Smoking Risky for Fetus

By HospiMedica staff writers
Posted on 09 Aug 2005
A study has found evidence of genetic mutation in cord blood from newborns that suggests second-hand smoke is just as detrimental to a developing fetus as maternal smoking.

In the new study, researchers looked at mutation rates at the HPRT gene located on the x chromosome in cord blood samples from newborns. More...
They looked for frequency of induced mutation as well as the resulting molecular spectrum of mutations. In particular, the new analysis redefines the nonsmokers used as controls to consider their exposure to tobacco smoke through other family members at home, at work, or in social situations.

"This analysis shows not only that smoking during pregnancy causes genetic damage that can be detected at birth but also that passive--or secondary--smoke exposure causes just as much damage as active smoking and it is the same kind of damage,” noted study author Stephen G. Grant, Ph.D., associate professor of environmental and occupational health at the University of Pittsburgh Graduate School of Public Health (PA, USA).

The new study was published in the July 26, 2005, issue of the online journal BMC Pediatrics. Earlier studies that considered the effects of tobacco on fetuses largely discounted the effects of secondary smoke.

"These kinds of mutations are likely to have lifelong repercussions for the exposed fetus, affecting survival, birth weight, and susceptibility to disease, including cancer,” added Dr. Grant.




Related Links:
U. of Pittsburgh Graduate School of Public Health

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.